Physician

Amit Varma, MD

According to 2025 Medicare claims, Amit Varma, MD (NPI: 1477762425) practices advanced heart failure and transplant cardiology in the Lancaster, PA market, with the plurality of this provider's patient population coming from Lancaster, PA. This provider's primary affiliated billing organization is THE HEART GROUP OF LANCASTER GENERAL HEALTH (NPI: 1760793210; TIN: 300634510) and primary practice location at 17603-2962. Varma is affiliated with the Lancaster General Health Community Care Collaborative, LLC (ACO ID: A2019), participating under the MSSP model.

Varma's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 863 traditional Medicare patients, billed 1,915 HCPCS/CPT codes, and received $116,560 in Medicare payments. The top billing code was 99215 (Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more). Part D data shows 1,644 prescription claims across 425 beneficiaries totaling $2,836,338 in drug costs, led by Vyndamax (Tafamidis). DME data shows 48 claims. Open Payments data shows 19 records totaling $326. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing did not follow a clear longitudinal pattern. Concurrently, Part D prescription costs have moved sharply higher in recent years, from $12,529 to $2,836,338. In contrast, DME billing represents a smaller volume and moved up and down with repeated peaks and valleys, starting at $1,289 and ending at $3,518.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	323	546	$30,754
2016	1,137	2,235	$125,298
2017	1,443	2,889	$149,473
2018	1,677	3,051	$140,105
2019	1,257	2,486	$145,987
2020	841	1,604	$107,843
2021	989	1,819	$123,218
2022	1,076	1,832	$101,367
2023	859	1,546	$99,921
2024	863	1,915	$116,560

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	93	380	$12,529
2016	229	1,159	$42,505
2017	288	1,536	$75,882
2018	362	1,709	$94,190
2019	388	1,559	$140,891
2020	321	1,364	$336,577
2021	313	1,049	$96,224
2022	348	1,423	$397,162
2023	402	1,520	$572,533
2024	425	1,644	$2,836,338

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	68	$2,000
2017	N/R	72	$1,879
2018	N/R	64	$2,179
2019	N/R	N/R	N/R
2020	N/R	180	$15,479
2021	N/R	39	$2,706
2022	N/R	32	$2,208
2023	N/R	N/R	N/R
2024	N/R	48	$3,107

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99215	Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more	68	83	$133
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	250	391	$90
93297	Evaluation of implantable heart and blood vessel monitoring system, remote up to 30 days	196	246	$44
93290	Evaluation of implantable heart and blood vessel monitoring system	96	127	$33
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	228	360	$12

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Vyndamax	Tafamidis	116	3,480	$2,528,765
Eliquis	Apixaban	91	5,402	$101,291
Entresto	Sacubitril/Valsartan	64	3,720	$77,172
Jardiance	Empagliflozin	46	3,060	$56,701
Farxiga	Dapagliflozin Propanediol	14	1,140	$21,528

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
A4222	Infusion supplies for external drug infusion pump, per cassette or bag (list drugs separately)	N	N/R	17	$2,301
J2260	Injection, milrinone lactate, 5 mg	N	N/R	18	$556
A4221	Supplies for maintenance of non-insulin drug infusion catheter, per week (list drugs separately)	N	N/R	13	$249

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	19	$326	Novartis Pharmaceuticals Corporation
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Amit Varma, MD?

Tedicare shows public-source Medicare data for Amit Varma, MD (NPI 1477762425), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Amit Varma, MD have ACO affiliation data?

Amit Varma, MD is shown with ACO affiliation data for Lancaster General Health Community Care Collaborative, LLC (MSSP, ACO ID A2019).

What billing organization is linked to Amit Varma, MD?

Amit Varma, MD is linked to THE HEART GROUP OF LANCASTER GENERAL HEALTH (billing NPI 1760793210) in the available physician profile data.

Does Amit Varma, MD have Open Payments data?

Amit Varma, MD has 19 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.